HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Interstitial pneumonia after CMC (CDDP, MMC, CPM) therapy].

Abstract
Six patients receiving CDDP, MMC, and CPM chemotherapy for adjuvant chemotherapy after a resection due to lung cancer developed interstitial pneumonia. They were re-admitted for dyspnea, shortness of breath, and dry cough from 80 to 118 days from start of their treatment. On re-admission, their chest radiographs showed reticular infiltrates, and their laboratory data showed severe hypoxemia. The pathological findings of a transbronchial lung biopsy showed a thickening of the alveolar septa. Steroid therapy resulted in a complete resolution in one patient and a partial resolution the 5 others. One year later, two patients had died, one patient remains in complete resolution, but a shortness of breath still exists in the remaining three patients. Considering the disadvantages of that shortness of breath can cause to daily life, we should be more cautious about administering antineoplastic agents for adjuvant chemotherapy to patients with a cancer in an early stage.
AuthorsM Sagawa, S Takahashi, K Usuda, K Kamma, M Satoh, S Ohta, N Nagamoto, T Imai, Y Saitoh, H Suda
JournalGan no rinsho. Japan journal of cancer clinics (Gan No Rinsho) Vol. 34 Issue 2 Pg. 150-4 (Feb 1988) ISSN: 0021-4949 [Print] JAPAN
PMID3126331 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Mitomycins
  • Mitomycin
  • Cyclophosphamide
  • Cisplatin
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)
  • Carcinoma, Squamous Cell (drug therapy, surgery)
  • Cisplatin (adverse effects)
  • Combined Modality Therapy
  • Cyclophosphamide (adverse effects)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, surgery)
  • Male
  • Middle Aged
  • Mitomycin
  • Mitomycins (adverse effects)
  • Pneumonectomy
  • Postoperative Period
  • Pulmonary Fibrosis (chemically induced, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: